Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
about
KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery.Reassessing the Potential of Myb-targeted Anti-cancer Therapy.A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity
P2860
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
@en
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
@nl
type
label
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
@en
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
@nl
prefLabel
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
@en
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
@nl
P2093
P2860
P356
P1433
P1476
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
@en
P2093
G Williams
M M van den Heuvel-Eibrink
O Williams
P2860
P2888
P304
P356
10.1038/LEU.2017.317
P577
2017-11-01T00:00:00Z